• Apicidin Disrupts Oocyte Maturation and Histone Acetylation

  2026-08-16

  The reference study identifies a reproductive-toxicity mechanism for Apicidin, showing that exposure impairs oocyte meiotic maturation through spindle, chromosome, actin, and histone-acetylation abnormalities. Its integrated cellular and epigenetic design provides a useful framework for evaluating how an established histone deacetylase inhibitor and emerging mycotoxin may compromise oocyte quality.

• Iptacopan: Translating Factor B Biology to Impact

  2026-08-15

  Iptacopan (LNP023) illustrates how selective, oral alternative pathway control can connect complement biology to translational strategy. This thought-leadership analysis links factor B mechanism, assay design, animal models, PNH evidence, and indication-level decision-making.

• U0126-EtOH: Designing Causal MEK1/2 Assays

  2026-08-14

  U0126-EtOH is a selective MEK1/2 inhibitor for dissecting ERK signaling with greater causal precision. This guide connects neuronal oxidative-stress assays, asthma inflammation models, and a key ERK5 study to practical experimental decisions.

• Foretinib (GSK1363089) Assay Workflows

  2026-08-14

  Build more informative Foretinib response studies by separating growth arrest from cell killing and pairing viability data with motility measurements. This workflow also shows how a multikinase profile can be translated from cell assays into cancer metastasis model and ovarian cancer xenograft planning.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-08-13

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA for research workflows such as PCR product contamination elimination. It is not intended for RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.

• Lysoptosis: Serpins, Cathepsins, and Cell Death

  2026-08-13

  The reference study establishes lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death pathway that emerges when intracellular serpins fail to restrain lysosomal cysteine proteases. By comparing Caenorhabditis elegans, mouse, and human models, it connects lysosomal membrane permeabilization and cathepsin L activity to a defined mechanism rather than treating them as nonspecific late-stage features of cell death.

• 5X Protein Loading Buffer (Reducing) Guide

  2026-08-12

  5X Protein Loading Buffer (Reducing) is a concentrated protein loading buffer for reducing SDS-PAGE sample preparation, where SDS denaturation and disulfide-bond reduction support protein molecular weight separation. It should be used for conventional denaturing electrophoresis and avoided when native protein conformation, intact disulfide-linked assemblies, or non-reducing conditions must be preserved.

• Gut Dysbiosis, STAT3, and Docetaxel Resistance

  2026-08-12

  Zhong et al. connect antibiotic-associated gut dysbiosis with prostate cancer progression and docetaxel resistance through a gut permeability–lipopolysaccharide–NF-κB-IL6-STAT3 pathway. By combining mouse tumor models, fecal microbiota transplantation, 16S rRNA sequencing, mechanistic assays, and patient samples, the study links microbial composition with both tumor biology and metastatic risk.

• AI Analysis of Urine Stem Cell Mitochondria in AD

  2026-08-11

  A 2025 Neurotherapeutics study developed a deep-learning workflow that classifies mitochondrial hyperfission and hyperfusion from live-cell fluorescence images of urine-derived stem cells. By connecting non-invasive cell collection with mitochondrial morphology analysis, the work provides a promising but preliminary route toward accessible Alzheimer’s disease and mild cognitive impairment biomarker research.

• Tankyrase Inhibitors and Hippo Signaling in HCC

  2026-08-11

  Jia et al. showed that the tankyrase inhibitors XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity and increasing the YAP-negative regulators AMOTL1 and AMOTL2. The study connects tankyrase activity to Hippo pathway regulation and provides a mechanistic framework for evaluating tankyrase inhibition beyond its established links to Wnt signaling.

• Dacomitinib (PF-00299804) Cancer Research Workflows

  2026-08-10

  Dacomitinib (PF-00299804) provides a durable pan-HER perturbation strategy for mapping EGFR, HER2, and HER4 signaling, resistance, apoptosis, and cell-cycle responses. This applied guide connects receptor-level experiments with the mitochondrial ferroptosis framework reported in colorectal cancer while clearly separating validated evidence from exploratory assay design.

• Stattic for Reproducible STAT3 Assays

  2026-08-09

  A scenario-based guide to using Stattic as a mechanistic STAT3 inhibitor in viability, proliferation, apoptosis, and radiosensitization workflows. It explains how SKU A2224 supports better assay interpretation through defined potency, handling requirements, and pathway-focused controls.

• Nigericin sodium salt: Practical Assay Guide

  2026-08-08

  Nigericin sodium salt is a potassium ionophore for experimentally perturbing K+/H+ exchange, membrane ion gradients, and cytoplasmic pH in research assays. It is intended for controlled in vitro workflows, not diagnostic or therapeutic use, and its solvent limitations and ionic-environment dependence must be addressed during assay development.

• Seeing the Invisible in Translational Neuroscience

  2026-08-07

  Translational neuroscience increasingly depends on proving not only that an intervention works, but also where its molecular machinery is expressed. This thought-leadership article connects the K+-selective channelrhodopsin strategy reported by Duan and colleagues with the Fluorescein TSA Fluorescence System Kit, showing how high-sensitivity spatial assays can strengthen mechanistic validation without overstating preclinical evidence.

• Vasopressin Analogues: Multitasking Peptides in Therapy and

  2026-08-07

  The reference study systematically examines vasopressin and its analogues, highlighting the evolution from natural hormones to versatile therapeutic peptides. It provides a detailed account of molecular modifications, clinical applications, and emerging antiviral prospects, with lypressin acetate serving as a key example of translational peptide utility.

11415 records 1/761 page Next 12345 下5页 Last page